These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15017816)

  • 1. Cardiomyopathy.
    Cruickshank S
    Nurs Stand; 2004 Feb 18-24; 18(23):46-52; quiz 54-6. PubMed ID: 15017816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk stratification in non ischemic cardiomyopathy: a case report--Case 5/2010].
    Parade U; Klingel K; Kandolf R; Gawaz M; Schreieck J
    Dtsch Med Wochenschr; 2010 Jun; 135(22):1122. PubMed ID: 20514634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advising a cardiac disease gene positive yet phenotype negative or borderline abnormal athlete: is sporting disqualification really necessary?
    Richard P; Denjoy I; Fressart V; Wilson MG; Carré F; Charron P
    Br J Sports Med; 2012 Nov; 46 Suppl 1():i59-68. PubMed ID: 23097481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of sudden cardiac death.
    Spector PS
    Heart; 2005 Mar; 91(3):408-13. PubMed ID: 15710742
    [No Abstract]   [Full Text] [Related]  

  • 5. Amyloid heart disease.
    Falk RH; Dubrey SW
    Prog Cardiovasc Dis; 2010; 52(4):347-61. PubMed ID: 20109604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiomyopathies: a practical approach to the assessment and management of patients and their families].
    Hiestand R; Gruner C
    Ther Umsch; 2024 Apr; 81(2):60-66. PubMed ID: 38780212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arrhythmias in cardiomyopathies].
    Kaneko Y; Kurabayashi M
    Nihon Rinsho; 2002 Jul; 60(7):1434-9. PubMed ID: 12136626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State-of-the-art management of hypertrophic cardiomyopathy in children.
    Berger S; Dhala A; Dearani JA
    Cardiol Young; 2009 Nov; 19 Suppl 2():66-73. PubMed ID: 19857352
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiomyopathies. I: classification of cardiomyopathies--dilated cardiomyopathy].
    Schultheiss HP; Noutsias M; Kühl U; Lassner D; Gross U; Poller W; Pauschinger M
    Internist (Berl); 2005 Nov; 46(11):1245-56; quiz 1257. PubMed ID: 16228156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can an athlete have too much ticker? Hypertrophic cardiomyopathy in young athletes.
    Fitzgerald NM; Sherwood M; Fitzgerald DA
    J Paediatr Child Health; 2012 Oct; 48(10):E156-60. PubMed ID: 22846097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac amyloidosis: an approach to diagnosis and management.
    Halwani O; Delgado DH
    Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):1007-13. PubMed ID: 20602561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empty handed: a call for an international registry of risk stratification to reduce the 'sudden-ness' of death in patients with non-compaction cardiomyopathy.
    Caliskan K; Kardos A; Szili-Torok T
    Europace; 2009 Sep; 11(9):1138-9. PubMed ID: 19706638
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic testing in cardiomyopathies: an update on indications and benefits.
    Aleksova N; Rutberg J; Green M; Haddad H
    Curr Opin Cardiol; 2017 Mar; 32(2):189-195. PubMed ID: 27861187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sudden death: from epidemiology to therapeutic management-prevention].
    Aliot E
    Arch Mal Coeur Vaiss; 2000 Jun; Spec No():27-9. PubMed ID: 10949712
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary prophylaxis of sudden death in hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and dilated cardiomyopathy.
    Klein GJ; Krahn AD; Skanes AC; Yee R; Gula LJ
    J Cardiovasc Electrophysiol; 2005 Sep; 16 Suppl 1():S28-34. PubMed ID: 16138882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac sarcoidosis].
    Chapelon-Abric C
    Ann Med Interne (Paris); 2001 Mar; 152(2):125-33. PubMed ID: 11357049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac magnetic resonance for risk stratification: the sudden death risk portrayed.
    Villuendas R; Kadish AH
    Prog Cardiovasc Dis; 2008; 51(2):128-34. PubMed ID: 18774012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden cardiac death markers in non-ischemic cardiomyopathy.
    Pimentel M; Rohde LE; Zimerman A; Zimerman LI
    J Electrocardiol; 2016; 49(3):446-51. PubMed ID: 27016256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of a case of peripartum cardiomyopathy.
    Baughman KL
    Nat Clin Pract Cardiovasc Med; 2006 Sep; 3(9):514-8; quiz 518. PubMed ID: 16932769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystrophies and heart disease.
    Cox GF; Kunkel LM
    Curr Opin Cardiol; 1997 May; 12(3):329-43. PubMed ID: 9243091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.